New York Times Editorial on Heparin: American Public Vulnerable to Toxic Imports
Hundreds of patients have now fallen ill due to the toxic batches of Heparin emanating from China.
In response, a New York Times editorial on April 28, 2008, cites the "sloppy manufacturing processes" involved and warns that it is essential that "American companies, eager to cut cost by outsourcing, are especially diligent about monitoring their suppliers.Some lots of heparin, whose main ingredient was made from pig intestines and imported from China, were contaminated with a cheaper substance derived from animal cartilage, Baxter and the FDA said last month.
This warning comes too late for those patients that have experienced severe side effects or even death after receiving Heparin bloodthinnner.
The Food and Drug Administration has now linked the contaminated drug to 81 deaths in the United States.
"All companies must ensure the quality and safety of what they buy and what they sell," said the Times.
If you were harmed after being administered heparin, please complete the form below and a representative of our firm will contact you as soon as possible.
see also:
Heparin Factors
Possible Intentional Contamination Factors into Heparin InvestigationFactors for tainted heparin include intentional sabotage--Lawsuit Info
Toxic Heparin
NYT Editorial on Heparin: American Public Vulnerable to Toxic Imports Toxic Heparin due to cost-cutting and sloppy process--lawsuit reviews
Heparin News, 2.28.07
Breaking News: Baxter Recalls Most Heparin Products After 4 DieHeparin Pulled From Market After News of Illness--Free Lawsuit Info
